Production / Operations
Herbal Dispatch Completes First International Gummy Export, Generates $350,000 in Revenue and Advances Global Edibles Strategy
Export Milestone Validates Strategy But Revenue Impact Remains Marginal Relative to Losses

Executive Summary
- Herbal Dispatch Inc. completed its first international export of medical cannabis gummies to Australia on April 30, 2026.
- The shipment generated approximately $350,000 in revenue from a top three global cannabis company customer.
- Products are compliant with Canadian federal regulations and GMP standards.
- Management anticipates follow-on shipments in 2026 subject to regulatory approvals.
- Existing international footprint includes Australia, Portugal, Germany, Brazil, Czech Republic, UK, Switzerland, and Costa Rica.
- Domestic strategy continues to expand the "Chomp" brand edibles offerings within Canada.
- Industry context provided includes Organigram Global Inc.'s acquisition of Sanity Group and British American Tobacco investment, signaling sector consolidation but not directly impacting Herbal Dispatch operations.
Material Impact
- The $350,000 revenue from a single export tranche is immaterial relative to Full Year 2025 gross sales of $16.5 million (approx. 2% of annual run rate).
- This announcement confirms execution capability for the "International B2B Exports" strategic pillar outlined in December 2025, but does not fundamentally alter the financial model.
- The news is consistent with previous export milestones announced in January and February 2026 (Germany/Portugal shipments), indicating a steady progression rather than a sudden breakthrough.
- No new financing or M&A activity was disclosed for Herbal Dispatch specifically; the Organigram/BT Tobacco news is sector-wide context.
- The positive sentiment supports the stock but lacks the magnitude to justify a "Material - Positive" rating given the company's ongoing full-year losses and small absolute revenue contribution from this specific deal.
HERB · Price
Company Overview
- Business Model: Cannabis distribution platform focusing on medical cannabis sales to veterans, recreational edibles ("Chomp" brand), and international B2B exports.
- Flagship Project: Expansion of high-margin export channels (gummies/medical flower) to Europe and Australia combined with domestic e-commerce growth.
- Market Position: Active in Canadian medical/recreational markets with growing international footprint; listed on CSE, Frankfurt Stock Exchange, and OTCQB (LUFFF).
- Operational Status: Achieved positive Adjusted EBITDA in Q4 2025 ($100k) but reported negative full-year Adjusted EBITDA for 2025 (-$700k).
More from Herbal Dispatch Inc.
Jun 16, 2026 · 03:02